These symptoms may indicate a different condition or suggest that your treatment plan needs adjustment
Eczema is driven primarily by type 2 inflammation, involving IL-4, IL-13, and IL-31 pathways
If you experience any unexpected symptoms after administration including nausea, vomiting, injection site swelling or redness, signs of allergic reaction (rash, difficulty breathing, swelling of the face or throat), or systemic symptoms such as fever you should: Contact your GP promptly for non-urgent concerns Call NHS 111 if you are unsure whether your symptoms require urgent attention Call 999 or attend A&E immediately if you experience a severe allergic reaction, chest pain, difficulty breathing, or loss of consciousness Suspected side effects or adverse reactions to any medicine, including investigational products, should be reported to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk
Starting during a relatively calm period rather than alongside major life changes sets you up for success
A new study examined short-term changes in food noise in a digital behavioral weight management program both with and without GLP-1 drugs